Emergent BioSolutions’ Growth Potential: Ebola Vaccine Contract, Naloxone Expansion, and Monkeypox Study Drive Buy Rating
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Emergent Biosolutions (EBS – Research Report), with a ...